Login / Signup

Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series.

Kent DoiMahoko IkedaNaoki HayaseKyoji MoriyaNaoto Morimuranull null
Published in: Critical care (London, England) (2020)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • sars cov
  • newly diagnosed
  • prognostic factors